{"disease":{"id":"graft-vs-host-disease","name":"graft vs host disease"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00106925","title":"Long-term Evaluation and Follow-up Care of Patients Treated With Stem Cell Transplants","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":false},{"nct_id":"NCT00092235","title":"Natural History Study of Clinical and Biological Factors Determining Outcomes in Chronic Graft-Versus-Host Disease","phase":"","overall_status":"RECRUITING","enrollment_count":650,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT04044365","title":"Pediatric cGVHD Symptom Scale","phase":"","overall_status":"RECRUITING","enrollment_count":420,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT02913261","title":"Safety and Efficacy of Ruxolitinib Versus Best Available Therapy in Patients With Corticosteroid-refractory Acute Graft vs. Host Disease After Allogeneic Stem Cell Transplantation","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":310,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT07210242","title":"HCMV-miRNA Monitoring After Allogeneic Hematopoietic Stem Cell Transplantation Using PSTM-qPCR","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":300,"lead_sponsor_name":"Ting YANG","has_results":false},{"nct_id":"NCT03229200","title":"Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.","phase":"PHASE4","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":297,"lead_sponsor_name":"Pharmacyclics Switzerland GmbH","has_results":false},{"nct_id":"NCT06143501","title":"Alterations in Intestinal Microbiota, Metabolites, and Immune Cells in Allo-HSCT","phase":"","overall_status":"UNKNOWN","enrollment_count":250,"lead_sponsor_name":"The First Affiliated Hospital of Soochow University","has_results":false},{"nct_id":"NCT01743131","title":"Abatacept as GVHD Prophylaxis Phase 2","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":186,"lead_sponsor_name":"Boston Children's Hospital","has_results":true},{"nct_id":"NCT02867384","title":"Obinutuzumab in cGVHD After Allogeneic Peripheral Blood Stem Cell Transplantation","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":181,"lead_sponsor_name":"Dana-Farber Cancer Institute","has_results":true},{"nct_id":"NCT04738981","title":"Efficacy and Safety of UC-MSCs for the Treatment of Steroid-resistant aGVHD Following Allo-HSCT","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":130,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT06080490","title":"Tacrolimus Blood Concentration and Transplant-related Outcomes in Pediatric HSCT Recipients","phase":"","overall_status":"COMPLETED","enrollment_count":125,"lead_sponsor_name":"University of Pisa","has_results":false},{"nct_id":"NCT07184853","title":"Ruxolitinib Plus Etanercept vs Ruxolitinib for Steroid-Refractory Severe Acute GVHD","phase":"NA","overall_status":"RECRUITING","enrollment_count":122,"lead_sponsor_name":"First Affiliated Hospital of Zhejiang University","has_results":false},{"nct_id":"NCT05111834","title":"IRENE-G Study: Impact of Resistance Exercise and Nutritional Endorsement on GvHD Symptoms","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":112,"lead_sponsor_name":"University Hospital Heidelberg","has_results":false},{"nct_id":"NCT00001830","title":"Donor Th2 Cells to Prevent Graft-Versus-Host Disease in Bone Marrow Transplants","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":110,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT00001873","title":"The Role of Cyclosporine in Blood Cell Transplants With T-Cell Add-Back for Blood Cancers","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":102,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":false},{"nct_id":"NCT05238155","title":"Evaluation of the Impact of Reduced Immunosuppression","phase":"","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Methodist Health System","has_results":false},{"nct_id":"NCT03136757","title":"Analysis of Transcriptomic Profile of Graft-versus-host Disease (GHVD) After Allogeneic Grafting of Hematopoietic Stem Cells","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Centre Hospitalier Universitaire, Amiens","has_results":false},{"nct_id":"NCT05333978","title":"Optoacoustic Detection of Inflammation Using MSOT Device","phase":"NA","overall_status":"SUSPENDED","enrollment_count":100,"lead_sponsor_name":"University of Oklahoma","has_results":false},{"nct_id":"NCT02876679","title":"Cyclophosphamide Versus Anti-thymocyte Globulin for GVHD Prophylaxis After RIC Allo-SCT","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":94,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT04337515","title":"A Feasibility Study Using CLINIMACS® for Alpha/Beta T-Cell Depletion in Stem Cell Transplant","phase":"NA","overall_status":"RECRUITING","enrollment_count":90,"lead_sponsor_name":"Christopher Dvorak","has_results":false},{"nct_id":"NCT04479995","title":"Multidisciplinary Intervention In Chronic GVHD","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":80,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT01665677","title":"Atorvastatin as GVHD Prophylaxis for Allogeneic Hematopoietic Cell Transplantation","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":69,"lead_sponsor_name":"Mehdi Hamadani","has_results":true},{"nct_id":"NCT00391170","title":"Dexamethasone to Prevent Oral Chronic Graft-versus-Host Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":62,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":true},{"nct_id":"NCT03591874","title":"Study of Brimonidine Tartrate Nanoemulsion Eye Drops in Patients With Ocular Graft-vs-Host Disease","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":59,"lead_sponsor_name":"Ocugen","has_results":true},{"nct_id":"NCT02105766","title":"Nonmyeloablative Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease and Beta-thalassemia in People With Higher Risk of Transplant Failure","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":56,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":true},{"nct_id":"NCT01713400","title":"Tacrolimus, Sirolimus and Ustekinumab vs. Tacrolimus and Sirolimus for the Prevention of Acute Graft-Versus-Host Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":54,"lead_sponsor_name":"H. Lee Moffitt Cancer Center and Research Institute","has_results":true},{"nct_id":"NCT02841995","title":"A Study to Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Chronic Graft Versus Host Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":54,"lead_sponsor_name":"Kadmon, a Sanofi Company","has_results":true},{"nct_id":"NCT05531786","title":"Phase I/II Study of Pacritinib, A JAK2/IRAK1/CSF1R Inhibitor, in Refractory Chronic Graft-Versus-Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT03731624","title":"Diadenosine Polyphosphates and Mucin Associated With Ocular Surface Disorders","phase":"","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation","has_results":false},{"nct_id":"NCT06824103","title":"Study of Efficacy and Safety of Ruxolitinib in Chinese Participants With Corticosteroid-refractory Chronic Graft vs. Host Disease","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT05132166","title":"A Randomized Phase II Study to Compare the Potential Long-Lasting Positive Effect of Decidual Stromal Cells to the Best Available Treatment in Graft Versus Host Disease","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":50,"lead_sponsor_name":"University Health Network, Toronto","has_results":false},{"nct_id":"NCT04014790","title":"RGI-2001 for the Prevention of Acute Graft-vs-Host Disease in Subjects Following Allogeneic Hematopoietic Stem Cell Transplantation","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":49,"lead_sponsor_name":"Regimmune Corporation","has_results":true},{"nct_id":"NCT07006506","title":"A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell Transplant","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":46,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":false},{"nct_id":"NCT03774082","title":"Activity, Safety and Pharmacokinetics in Pediatric Subjects With Moderate and Severe Chronic Graft vs. Host Disease After Allogeneic Stem Cell Transplant","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":46,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT03842696","title":"Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":43,"lead_sponsor_name":"University of Michigan Rogel Cancer Center","has_results":false},{"nct_id":"NCT05780554","title":"Post-transplantation Cyclophosphamide in Haploidentical Stem Cell Allografts Dose Reduction: 50 mg/kg vs 25 mg/kg","phase":"NA","overall_status":"UNKNOWN","enrollment_count":42,"lead_sponsor_name":"Centro de Hematología y Medicina Interna","has_results":false},{"nct_id":"NCT00001623","title":"Bone Marrow Transplant Studies for Safe and Effective Treatment of Leukemia","phase":"NA","overall_status":"COMPLETED","enrollment_count":41,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":false},{"nct_id":"NCT06008808","title":"Ruxolitinib With and Without CTLA-4 Ig Abatacept for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":41,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT04558788","title":"Cellular Stress Reactions During Graft-versus-host Disease","phase":"","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"University of Freiburg","has_results":false},{"nct_id":"NCT01557517","title":"Clobetasol for Oral Graft-Versus-Host Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT02891603","title":"A Phase I/II GVHD Prevention Trial Combining Pacritinib With Sirolimus-Based Immune Suppression","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"H. Lee Moffitt Cancer Center and Research Institute","has_results":true},{"nct_id":"NCT02683525","title":"Sitagliptin for Prevention of Acute Graft Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":37,"lead_sponsor_name":"Sherif S. Farag","has_results":true},{"nct_id":"NCT05236062","title":"Impact of Exercise on the Complications of Corticosteroids in Patients With GVHD: the RESTART Trial","phase":"NA","overall_status":"RECRUITING","enrollment_count":36,"lead_sponsor_name":"Dana-Farber Cancer Institute","has_results":false},{"nct_id":"NCT07364617","title":"Fecal Microbiota Transplantation for Steroid-Refractory Acute GI GVHD","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":35,"lead_sponsor_name":"Chang Gung Memorial Hospital","has_results":false},{"nct_id":"NCT01688466","title":"Pomalidomide for Chronic Graft-versus-Host Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":34,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT00136903","title":"Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"Mesoblast, Inc.","has_results":false},{"nct_id":"NCT04678401","title":"IS-free Treg HaploHCT","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Dana-Farber Cancer Institute","has_results":false},{"nct_id":"NCT07365696","title":"Fatigue and Cognitive Dysfunction Due to Synaptopathy or Graft Versus Host (GVH) Disease in the Brain.","phase":"","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Karolinska University Hospital","has_results":false},{"nct_id":"NCT02406651","title":"Study of IL-22 IgG2-Fc (F-652) for Subjects With Grade II-IV Lower GI aGVHD","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"EVIVE Biotechnology","has_results":true},{"nct_id":"NCT03315741","title":"The Safety and Tolerability of Pirfenidone for BOS After HCT","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Stanford University","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}